- This section mostly covers lower-extremity atherosclerotic arterial disease. Aortic disease and cerebrovascular disease are covered elsewhere.
- Early diagnosis useful, even if asymptomatic, as presence of PAD correlates to an increase in CV risk
Risk factors
- The standard CV risk factors apply, though some genetic predispositions especially in regards to thoracic aortic dissection
- People with PAD are 3 x more likely to die of CV disease than someone without PAD
- Not all people with acute ischemia have risk factors
- DM and smoking increase risk of PAD by about 3-fold
- 60% of those with chronic limb threatening ischemia have DM (and patients less likely to be symptomatic due to peripheral neuropathy)
- DM actually reduces the risk of aortic aneurysm and dissection
- Generally speaking PAD is a bit more common in women
Vascular examination
- Assess for bruits (femoral, aortic, carotid) and pulses
-
- Check carotid (a bruit doubles the risk of CV death), heart, abdomen, femorals, legs and feet (popliteal, dorsalis pedis, TP)
- Can check BP in both arms
-
- Legs
-
- Ulcers
- Temperature disparity between legs
- Muscle atrophy
- Skin changes (thin, shiny, discoloured, heel tissue loss, hair loss)
- Capillary Refill Time (although not reliable)
-
- Functional status
Chronic limb ischaemia – symptoms and aetiology
- Causes
-
- Mainly caused by atherosclerosis
- Occasionally caused by vasculitis, fibromuscular dysplasia, thromboembolism, Buerger’s disease, trauma, dissection, entrapment syndromes, cystic adventitial disease
-
- Asymptomatic peripheral arterial disease
-
- Might be picked up by clinical exam, or imaging for other reasons
- May have masked effort-related symptoms due to reduced walking capacity (for reasons other than PAD), or reduced pain sensitivity
-
- Symptomatic peripheral arterial disease
-
- Chronic lower limb wounds
- Intermittent claudication
-
- Pain in legs on walking – often cramp-like in the calf (most often)/thigh/buttock at a predictable distance, relieved by rest.
- Often remains stable, 15% worsen over 5 years, 5% develop critical ischaemia.
- Amputation eventually required in 1-2%
- Differentials include nerve root compression, spinal stenosis (bilateral pain, worse on standing, better on flexing lumbar spine), arthritis (eg hip, foot, ankle)
-
- Chronic limb threatening ischaemia (CLTI) is the more severe end of the spectrum
-
- Defined as any of: ischaemic rest pain, gangrene or non-healing chronic wound (>2 weeks) and critical limb perfusion (ankle pressure <50mmHg, toe pressure <30mmHg)
- Rest pain can be worse at night, people may sleep with leg hanging out of bed
- Tissue loss (ulcers, gangrene, infections)
- Poor prognosis without intervention
- Risk of limb loss – even greater if co-existent wound infection or DM
- 70% get revascularized. Some have amputations.
- 5-year all-cause mortality 50% (worse than some cancers)
- Can be confused with other causes of foot pain (planatar fasciitis gout, arthritis)
- If wounds present, can assess risk of amputation
-
-
Investigations in suspected chronic PAD
- Bloods – HbA1c, lipids, TFTs, LFTs, CRP
- ABPI (ankle brachial pressure index)
-
- Check when supine
- Put BP cuff on upper arm and use doppler to check signal – inflate until it stops. Repeat on the ankle checking signal in Tibialis Posterior and Dorsalis Pedis pulses. Do both arms and both legs.
- Divide highest ankle systolic pressure by highest brachial systolic pressure
- Normal 1-1.4 (or 0.8-1.3, depends on the guideline)
- >1.4 suggests non-compressible vessels /arterial calcification eg DM, severe CKD, advanced age, RA, vasculitis
- <0.9 suggests PAD and <0.5 suggests severe PAD
- 5-0.8 – PAD, or mixed arterial/venous disease
- However if ABPI normal – doesn’t exclude PAD
- Sensitivity for PAD is around 75% and specificity around 90%
- If symptoms suggestive but ABPI >0.9, can repeat it after exercising, which can help diagnose stenoses (a decrease of >20% can suggest PAD)
- If value very high (>1.4) – consider checking TBI, TcPO2, distal doppler waveforms.
-
- Duplex USS
-
- Best first line imaging test for PAD screening and diagnosis
- Sensitivity of 88% and specificity of 95% for >50% stenosis detection. Can also diagnose non-atherosclerotic lesions
-
- CT angio / MR angio
-
- For revascularisation planning
- CTA generally better than MRA (but can overestimate stenosis due to blooming effect)
-
- Echo
-
- Worth screening for co-existent HF as 25% of patients with PAD have LV dysfunction (mostly due to CAD).
- Aortic stenosis is also commonly associated with PAD
-
Management of chronic PAD
- General measures – reduce CV risk, foot care/podiatry, exercise programme for intermittent claudication
- For asymptomatic PAD – medical treatment and vascular team assessment
- For symptomatic PAD without wounds – medical treatment, home-based or supervised exercise training (unless chronic limb threatening ischaemia), vascular team assessment and consider intervention
- For PAD with wounds – wound care and healing before exercise regime
- Choice of intervention depends on the cause, site and feasibility
- Vascular interventions include catheter directed thrombolysis, endarterectomy, bypass surgery, angioplasty / stenting, amputation
- Revascularisation might be fem-pop, or aorto-iliac or below the knee
- Amputation usually best option for gangrene, or when revascularisation fails
- Below the knee amputation allows for better mobility / use of a prothesis, and above the knee often best if patient bedbound
- Exercise training
-
- Walking best
- May be limited by pain, but some patients may benefit to exercising though pain if can tolerate
- Should be at least 3 x week, >30 mins per session
-
- Medications
-
- Analgesia
- Treat hypertension
-
- ACE-I or ARBs probably 1st line, and advised in unilateral RAS
- Can use betablockers despite commonly held belief they are contraindicated
-
- Statin
- Single anti-platelet
-
- Aspirin has not been shown to reduce rates of amputation or revascularisation, but data lacking
- Improves CV prognosis nonetheless
- Clopidogrel may be slightly better than aspirin if symptomatic
-
- Dual antiplatelets – only generally used after endovascular therapy for 1-3 months. Long term treatment not recommended.
- Treat DM and aim HbA1c <53. Both SGLT2i and GLP-1RAs but particularly useful
- Naftidrofuryl oxalate for intermittent claudication if exercise hasn’t helped and not surgical candidate
- DOAC
-
- Indicated alongside aspirin in high-risk limb presentation eg CLTI, previous amputation or revascularisation, or high-risk comorbidities (DM, HF, poly-vascular disease) without high bleeding risk
- Also used after revascularisation
- Use ‘vascular dose’ of 2.5mg rivaroxaban BD
- Not used alone in PAD – should be with an antiplatelet
-
-
- Spinal cord stimulation – an option for CLTI and no revascularisation options. Reduces pain and amputation rate, but no effect on ulcer healing
Acute lower limb ischaemia
- Causes
-
- Usually due to rupture of an atherosclerotic plaque and subsequent thrombosis (80%).
- Occasionally caused by cardiac embolization, aortic dissection, graft thrombosis, thrombosis of popliteal aneurysm, trauma, hypercoagulable states, iatrogenic, phlegmasia cerulea dolens, ergotism
-
- Clinical features
-
- Sudden decrease in limb perfusion (< 2 weeks).
- Leg pain / sudden deterioration in claudication
- Loss of pulses, pallor, coldness, cyanosis, loss of sensation (or the 6 Ps – pain, pulseless, pallor, power loss, paraesthesia, perishingly cold)
- Onset very acute if due to embolisation, with white limb, and more gradual if due to thrombosis due to collaterals
- Can be complicated by compartment syndrome and reperfusion injury (rhabdo, arrythmias, AKI, MOF, DIC once blood flow restored)
- Often misdiagnosed – as peripheral neuropathy, DVT, chronic ischaemia with low cardiac output
- Higher rates of amputation the longer the delay to revascularisation
-
- Assessment
-
- Symptom duration is key
- Neurology is also key – sensory and motor (these are important signs of limb threat and require emergency imaging and revascularization). Paralysis suggest limb may not be salvageable
- Graded 1, 2A, 2B or 3
-
- 1 has best prognosis. Both arterial and venous signal on doppler
- 2A involves no sensory loss, or just in toes. No motor deficit. Loss of arterial doppler signal.
- 2B sensory loss in more than toes, and mild/mod motor deficit
- 3 involves profound sensory loss, paralysis, elevated biomarkers, no cap refill, no venous or arterial signal on doppler
-
- Urgent imaging – consider duplex, CTA, MRA (but imaging should not delay treatment)
- Check CK (once elevated, it’s a late sign)
- Later may require Holter, echo and aortic imaging as embolism a common cause. Also consider thrombophilia screening.
-
- Treatment
-
- Analgesia
- Anticoagulate – usually with unfractionated heparin infusion
- IV fluids
- Treat acidosis and hyperkalamia if required
- Urgent vascular review to consider intervention
-
Upper limb PAD
- Upper limb digital ischaemia is most frequently caused by non-atherosclerotic aetiologies, including thrombo-embolism, systemic sclerosis, idiopathic, thromboangiitis obliterans, iatrogenic, or cancer
- Atherosclerotic upper-limb artery disease is most frequently located in the subclavian artery
-
- Inter-arm BP difference can suggest subclavian stenosis
- Can lead to strokes, subclavian steal or severe ishcaemia
-
- Subclavian steal syndrome
-
- Can cause visual disturbances, syncope, ataxia, vertigo, dysphasia, dysarthria, and facial sensory deficits during arm movements
- Diagnose with duplex US. Often needs CTA too.
- Percutaneous angioplasty for subclavian arterial stenosis is often used with stenting
-
Other arterial disease
- Renal artery stenosis
-
- Hypertension at a young age, severe hypertension associated with CKD or HF, rapid worsening of previously controlled BP, or resistant hypertension
- Abdominal bruit
- Worsening renal function after starting ACEi
- Unexplained atrophic kidney or discrepancy in kidney size
- Flash pulmonary oedema
- Diagnose by duplex US (often 1st line), MRA or CTA
- May need catheter-based angiography if considering intervention
- Decision to intervene is based on viability of kidney, risk and imaging findings
-
- Acute mesenteric ischaemia
-
- Can be due to arterial emboli, thrombosis in situ, superior mesenteric artery construction, venous thrombosis
- May present with intense sudden abdo pain, vomiting and diarrhoea
- May be minimal clinical findings
- Might be a history of AF
- Do CTA
- Most patients require immediate revascularization to survive (either open surgery or endovascular)
-
- Chronic mesenteric artery disease
-
- Symptoms typically manifest when at least two mesenteric vessels are involved due to extensive collaterals
- May be post-prandial abdominal pain, weight loss, diarrhoea or constipation.
- Patients may develop food aversion to avoid pain, but their appetite remains unaffected, unlike cancer
- Bloods often normal
- Do CTA and consider intervention (again surgery vs endovascular, the former has better long-term results, the latter lower complications)
-